Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Platform Trial For Cryptococcal Meningitis — Stella

Home/Hiv/Platform Trial For Cryptococcal Meningitis

View on ClinicalTrials.gov

Recruiting

Back to Hiv trials

Platform Trial For Cryptococcal Meningitis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Uganda

Infectious Diseases Institute, Kampala

Mbarara University of Science and Technology, Mbarara

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

University of Minnesota

Enrollment target

~2,000 participants

Started

May 2025

Primary completion

April 2032

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.